WPP and Shire lose ground - guardian.co.uk
|
WPP and Shire lose ground
guardian.co.uk, UK - 1 hour ago And pharmaceuticals group Shire, which was boosted earlier this week by news of US approval for its Vyvanse ADHD treatment for adults, is now losing ground. … |
Find Out More:
Books:
- Understanding Girls With AD/HD
- ADHD: Attention-Deficit Hyperactivity Disorder in Children, Adolescents, and Adults
- Concerta Side Effects
- Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders
- Overcoming Autism: Finding the Answers, Strategies, and Hope That Can Transform a
April 25th, 2008
Vyvanse
Leave a Reply